| Dear All,
following the agreement on mutual cooperation between EFLM and W. de Gruyter for Clinical Chemistry and Laboratory Medicine journal (CCLM), it has been planned to send regularly to the EFLM contacts the table of contents of CCLM issues and the list of future titles as well. I do hope you will appreciate the initiative which is intended as a further service by EFLM to our European professional community. CCLM is published on a monthly basis and is the most relevant Journal on Clinical Chemistry in Europe; it is a valuable and updated source of knowledge for the professionals in the field, well recognized all over the world. The CCLM 2016 Impact Factor is 3.432.
With kindest regards, |
| A new issue of ‘Clinical Chemistry and Laboratory Medicine (CCLM)’ is available online from De Gruyter Online: Volume 56, Issue 3 (March 2018)
Click on the following links to view the new contents. Analytical quality: an unfinished journey Update in diagnosis and management of primary aldosteronism Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far Irregular analytical errors in diagnostic testing – a novel concept A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods Reaching consensus on communication of critical laboratory results using a collective intelligence method Stability of routine biochemical analytes in whole blood and plasma/serum: focus on potassium stability from lithium heparin GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients Interlaboratory variability of urinary iodine measurements The venous thromboembolic risk and the clot wave analysis: a useful relationship? Autovalidation and automation of the postanalytical phase of routine hematology and coagulation analyses in a university hospital laboratory Indirect method for validating transference of reference intervals Differences in levels of albumin, ALT, AST, γ-GT and creatinine in frail, moderately healthy and healthy elderly individuals Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy Hyperuricemia does not seem to be an independent risk factor for coronary heart disease Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease Preanalytics of ammonia: stability, transport and temperature of centrifugation Influence of delayed separation of plasma from whole blood on Cu, I, Mn, Se, and Zn plasma concentrations Copeptin as a diagnostic and prognostic biomarker in patients admitted to Emergency Department with syncope, presyncope and vertiginous syndrome Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal Athletes beware before throwing towels to audiences |
| European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Silvia Cattaneo – Via Carlo Farini, 81 – 20159 Milano – Italy Tel: +39 389 5320051– e-mail: [email protected] – website: www.eflm.eu |
